A single dose, randomized, controlled proof-of-mechanism study of a novel vasopressin 1a receptor antagonist (rg7713) in high-functioning adults with autism spectrum disorder
Daniel Umbricht, Marta Del Valle Rubido, Eric Hollander, James T. McCracken, Frederick Shic, Lawrence Scahill, Jana Noeldeke, Lauren Boak, Omar Khwaja, Lisa Squassante, Christophe Grundschober, Heidemarie Kletzl, Paulo Fontoura
Dive into the research topics of 'A single dose, randomized, controlled proof-of-mechanism study of a novel vasopressin 1a receptor antagonist (rg7713) in high-functioning adults with autism spectrum disorder'. Together they form a unique fingerprint.